Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Preferences for colorectal cancer screening of physicians and individuals at average risk in the United States: A discrete choice experiment.
Authors
Sebastian Heidenreich
Evidera Inc, London, United Kingdom
Sebastian Heidenreich , Lila J Finney Rutten , Lesley-Ann Miller-Wilson , Cecilia Moreno-Jimenez , Gin Nie Chua , Deborah Fisher
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
DOI
10.1200/JCO.2022.40.4_suppl.060
Abstract #
60
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical performance of a multimodal screening blood test for advanced adenomas and CRC in an average-risk cohort of 1,038 participants.
First Author: Shai Friedland
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of revising colorectal cancer screening guidelines on health care resources in Canada.
First Author: Brendan Chia
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Multisite external validation of blood test for colorectal neoplasia screening in a majority average-risk screening cohort of 449 subjects.
First Author: Shai Friedland
Poster
2023 ASCO Annual Meeting
The impact of extending CRC screening to the older population: Results from CRC-AIM microsimulation model.
First Author: Derek W. Ebner